Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

76 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Combinatorial peptide-based epitope mapping from Ebola virus DNA vaccines and infections reveals residue-level determinants of antibody binding.
Ripoll DR, Mitchell DAJ, Dupuy LC, Wallqvist A, Schmaljohn C, Chaudhury S. Ripoll DR, et al. Hum Vaccin Immunother. 2017 Dec 2;13(12):2953-2966. doi: 10.1080/21645515.2017.1360454. Epub 2017 Sep 18. Hum Vaccin Immunother. 2017. PMID: 28922082 Free PMC article.
Epitope mapping of Ebola virus dominant and subdominant glycoprotein epitopes facilitates construction of an epitope-based DNA vaccine able to focus the antibody response in mice.
Mitchell DAJ, Dupuy LC, Sanchez-Lockhart M, Palacios G, Back JW, Shimanovskaya K, Chaudhury S, Ripoll DR, Wallqvist A, Schmaljohn CS. Mitchell DAJ, et al. Among authors: Ripoll DR. Hum Vaccin Immunother. 2017 Dec 2;13(12):2883-2893. doi: 10.1080/21645515.2017.1347740. Epub 2017 Jul 12. Hum Vaccin Immunother. 2017. PMID: 28699812 Free PMC article.
A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses.
Koehler JW, Smith JM, Ripoll DR, Spik KW, Taylor SL, Badger CV, Grant RJ, Ogg MM, Wallqvist A, Guttieri MC, Garry RF, Schmaljohn CS. Koehler JW, et al. Among authors: Ripoll DR. PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2430. doi: 10.1371/journal.pntd.0002430. eCollection 2013. PLoS Negl Trop Dis. 2013. PMID: 24069485 Free PMC article.
76 results
Jump to page
Feedback